According to the Prostate Cancer Foundation, African American men are 64% more likely to develop prostate cancer compared with Caucasian men and are nearly 2.4 times more likely to die from the disease.
Read MoreCancer researchers have applied a comprehensive set of analytical tools to lethal cases of metastatic prostate cancer, yielding a detailed map of the complex networks of interactions among genes and proteins that enable prostate cancer cells to proliferate and evade treatment.
Read MoreAn enlarged prostate also known as benign prostatic hyperplasia (BPH), has been treated in various ways with one of them being the use of the dietary supplement saw palmetto.
Read MoreThe potential foundation for a next-generation therapy, called tetraaryl cyclobutane, or CB, is being studied as an option for prostate tumors that have grown resistant to current anti-androgen drugs, notably enzalutamide.
Read MoreAn extract of the spice actually kills human prostate cancer cells while healthy prostate cells did not die. The results of the study occurred at a daily dose of 100 mg of ginger extract per kg of body weight.
Read MoreCancer researchers have developed a computational approach for analyzing patient-specific data to help doctors choose the most effective drugs for individual patients.
Read MoreWhen a man schedules a prostate specific antigen test (PSA), there are certain activities he needs to avoid right before the test that can affect the results.
Read MoreMost men like a plan of action and here is a dietary plan all men should embrace that could curtail their chance of developing prostate cancer.
Read MoreAlthough it reads like European license plate number, a protein known as ZMYND8 has demonstrated its ability to block metastasis-linked genes in prostate cancer.
Read MoreIn the study published in the journal Oncotarget, 10 men with metastatic prostate cancer resistant to androgen deprivation therapy and the androgen receptor antagonist enzalutamide were treated with pembrolizumab, a monoclonal antibody that binds to the PD-1 receptor.
Read MoreOver 90 percent of prostate cancers are detected at a curable stage, with men more likely to die of other diseases than from this cancer.
Read More
